Immunome, Inc.

Immunome, Inc. is a biotech company focused on the discovery and development of next-generation antibody therapeutics. Leveraging its proprietary Immune Repertoire Platform, Immunome aims to harness the human immune response to develop innovative treatments for various diseases, including cancers and infectious diseases. The company's unique approach involves mining the human immune system for antibodies that can effectively target and neutralize disease-causing agents. Immunome is committed to addressing unmet medical needs by advancing new therapies that offer enhanced efficacy and safety profiles compared to existing options. Through its dedication to innovation and research, Immunome strives to become a leader in the biopharmaceutical industry, ultimately improving patient outcomes.